Identification of novel CLN2 mutations shows Canadian specific NCL2 alleles.
Ju
W
W
Zhong
R
R
Moore
S
S
Moroziewicz
D
D
Currie
J R
JR
Parfrey
P
P
Brown
W T
WT
Zhong
N
N
D017668:Age of Onset; D000483:Alleles; D000626:Aminopeptidases; D002170:Canada; D004247:DNA / Q000737:chemistry / Q000235:genetics; D004252:DNA Mutational Analysis; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D010450:Endopeptidases; D005192:Family Health; D018740:Genetic Heterogeneity; D006801:Humans; D007223:Infant; D009154:Mutation; D009472:Neuronal Ceroid-Lipofuscinoses / Q000235:genetics*; D010447:Peptide Hydrolases / Q000235:genetics*; D011110:Polymorphism, Genetic; D057057:Serine Proteases; D000091346:Tripeptidyl-Peptidase 1
D000091346:Tripeptidyl-Peptidase 1; D004247:DNA; D010450:Endopeptidases; D010447:Peptide Hydrolases; D057057:Serine Proteases; D000626:Aminopeptidases; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; C000717267:TPP1 protein, human